An Arizona man who has hepatitis C was not able to undergo a liver transplant, even when a dying friend volunteered to donate the organ, because his family was not able to raise $200,000. Starting Oct. 1, the Arizona Health Care Cost Containment System halted paying for such transplants as a result of the procedures' low success rate. The man was the first to miss a transplant because of the policy.
Phase III study data suggest that an ibuprofen-famotidine combination reduces the incidence of upper gastrointestinal events in patients taking long-term NSAIDs. A second study, also presented at the American College of Rheumatology, suggested that tablets of HZT-501, containing 800 milligrams of ibuprofen and 26.6 mg of famotidine, were well tolerated by patients.
People who ate three or more daily servings of whole grains and kept refined grains to less than one serving a day had 10% less belly fat than those who followed a different plan, researchers said. People who ate more than four servings of refined grains per day did not reduce visceral fat levels even if they also ate whole grains, the study found.
The CDC recently identified obesity as one of six "winnable" public health battles, but experts say it's a challenge that will require a serious commitment and a range of tactics. One pediatric endocrinologist said better urban planning, improved access to healthy foods and more physical activity in schools are needed to help slow the rise in obesity rates.
The FDA has declined to approve Arena Pharmaceuticals' weight-loss drug lorcaserin, citing concern about the medicine's potential risks and "minimal" effectiveness.
The agency asked for an independent review of a study demonstrating the growth of breast tumors in female rats treated with lorcaserin. "We will work with the agency to address the issues," CEO Jack Lief said.